Sale!

ANKH Gene Craniometaphyseal Dysplasia Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

Craniometaphyseal Dysplasia (CMD) is a rare genetic disorder characterized by abnormal bone growth in the skull and jaw, leading to distinctive facial features and dental abnormalities. The condition is caused by mutations in the ANKH gene, which plays a crucial role in bone development and mineralization. Identifying the specific genetic mutation responsible for CMD can provide valuable information for diagnosis, management, and genetic counseling of affected individuals and their families.

DNA Labs UAE offers a specialized genetic test targeting the ANKH gene to identify mutations associated with Craniometaphyseal Dysplasia. This test is pivotal for individuals showing symptoms of CMD or those with a family history of the disorder, providing a definitive diagnosis and facilitating appropriate medical interventions.

The cost of the ANKH Gene Craniometaphyseal Dysplasia Genetic Test at DNA Labs UAE is 4400 AED. Conducted in a state-of-the-art laboratory by experienced geneticists, the test offers a high degree of accuracy and reliability. Results from the test can help guide treatment plans and inform patients about the likelihood of passing the condition on to their offspring, thus playing a crucial role in the management of CMD.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ANKH Gene Craniometaphyseal dysplasia Genetic Test

Test Details

ANKH gene craniometaphyseal dysplasia NGS genetic testing is a type of genetic test that looks for mutations or variations in the ANKH gene associated with craniometaphyseal dysplasia. Craniometaphyseal dysplasia is a rare genetic disorder characterized by abnormal bone growth in the skull and facial bones, as well as metaphyseal dysplasia affecting the long bones.

NGS, or next-generation sequencing, is a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes or the entire exome or genome. In the case of ANKH gene craniometaphyseal dysplasia NGS genetic testing, the ANKH gene is specifically targeted for analysis. The test involves collecting a DNA sample, typically through a blood sample or a cheek swab, and sequencing the ANKH gene using NGS technology.

The sequencing data is then analyzed to identify any mutations or variations in the ANKH gene that may be associated with craniometaphyseal dysplasia. The results of the test can help confirm a diagnosis of craniometaphyseal dysplasia and provide information about the specific genetic mutation involved. This information can be used for genetic counseling, family planning, and potentially for the development of targeted treatments in the future.

Test Name

ANKH Gene Craniometaphyseal dysplasia Genetic Test

Components

Price: 4400.0 AED

Sample Condition

Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery

3 to 4 Weeks

Method

NGS Technology

Test Type

Dysmorphology

Doctor

Pediatrics

Test Department

Genetics

Pre Test Information

Clinical History of Patient who is going for ANKH Gene Craniometaphyseal dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ANKH Gene Craniometaphyseal dysplasia NGS Genetic DNA Test gene ANKH

Test Name ANKH Gene Craniometaphyseal dysplasia Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Dysmorphology
Doctor Pediatrics
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ANKH Gene Craniometaphyseal dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with ANKH Gene Craniometaphyseal dysplasia NGS Genetic DNA Test gene ANKH
Test Details

ANKH gene craniometaphyseal dysplasia NGS genetic testing is a type of genetic test that looks for mutations or variations in the ANKH gene associated with craniometaphyseal dysplasia. Craniometaphyseal dysplasia is a rare genetic disorder characterized by abnormal bone growth in the skull and facial bones, as well as metaphyseal dysplasia affecting the long bones.

NGS, or next-generation sequencing, is a high-throughput sequencing technology that allows for the simultaneous analysis of multiple genes or the entire exome or genome. In the case of ANKH gene craniometaphyseal dysplasia NGS genetic testing, the ANKH gene is specifically targeted for analysis.

The test involves collecting a DNA sample, typically through a blood sample or a cheek swab, and sequencing the ANKH gene using NGS technology. The sequencing data is then analyzed to identify any mutations or variations in the ANKH gene that may be associated with craniometaphyseal dysplasia.

The results of the test can help confirm a diagnosis of craniometaphyseal dysplasia and provide information about the specific genetic mutation involved. This information can be used for genetic counseling, family planning, and potentially for the development of targeted treatments in the future.